Haemophilus influenzae type B

Haemophilus influenzae type B
note_alt Sign up for vaccinations

Haemophilus influenzae type B

  • Age:vaccination of children at 2, 4 months, revaccination at 12 months

The vaccine and its manufacturer:
vaccines Hexaxime vaccines Hex's Infanrix vaccines Infanrix IPV HIB vaccines Pentaxim vaccines Hiberix

Description of the disease

Hemophilic infection type b is an infectious disease caused by the bacterium haemophilusinfluenzae, which affects the respiratory system, the brain, and also causes purulent foci in the organs.
The source of the disease is an infected person with bacteria present on the mucous respiratory tract for a long time.
Ways of transmission: airborne and contact method: through toys, dishes, bedding, etc. The most vulnerable are children under the age of 2. The risk group includes children aged 6-12 months who are on artificial feeding due to the lack of maternal antibodies that are present in breast milk.

  • Treatment

    Hemophilic infection is treated exclusively in a hospital with antibiotic therapy. Purulent meningitis and epiglottitis are treated with etiotropic therapy.

  • Prevention

    Prevention - vaccination against HIV infection (carried out up to 5 years).

  • Symptoms

    The disease often passes in a hidden form, but the following symptoms may be present: inflammation of the mucous membrane of the nasopharynx, upper respiratory tract; otitis media; in newborns, conjunctivitis, mastoiditis, purulent arthritis, blood infection are possible; meningitis or hemophilic meningitis; inflammation of the epiglottis (epiglottitis); cellulite (more often inflammation of fatty tissue on the face, redness, thickening in children under 12 months); sepsis.

  • Diagnostics

    Diagnosis - culture of sputum, laboratory examination of various tissues, cerebrospinal fluid for the presence of bacteria.